Lois Levine, MA

The US Food & Drug Administration is about to authorize use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years old.

Adverse childhood experiences (ACEs) are associated with poor health outcomes over the course of a life, but there is still little information on clinical workflows to guide these implementation practices. At the virtual 2021 virtual Pediatric Academic Societies meeting, Julia I. Reading discussed models and variations in ACE screening workflows.

The Bronx experienced 1 of the highest mortality rates of COVID-19 during the beginning of the pandemic. Some early research suggests that quarantine and school closures had a major psychosocial impact on children during this time. A study presented at the virtual 2021 Pediatric Academic Societies meeting looks at how children and teenagers living in low socioeconomic settings were affected by the pandemic.

The FDA announces 2 standards to reduce disease and death from tobacco products.

The American Academy of Pediatrics states that children accounted for almost 20% of new cases of COVID-19 during the week ending March 25, with more than 64,000 new cases reported.

Barry S. Zuckerman, MD, founder of Reach Out and Read, hopes to personalize the patient-doctor relationship with a new app called Small Moments.

A new scanning technology makes it easier to detect micro-strabismus and amblyopia.

A pediatric infectious disease specialist discusses where we are at with children's vaccines for COVID-19.

Believe it or not, there was a sunny side to 2020.

A look at how we learned to protect ourselves and our patients from COVID-19 over the past year.

Several reports coming out of the United Kingdom are suggesting that the newest variant of COVID-19 might be more infectious for children.

The National Institutes of Health award 8 research grants to develop ways to identify children at high risk for multi system inflammatory syndrome I children (MIS-C).

The FDA approves Xeomin (incobotulinumtoxinA) for chronic sialorrhea in children.

A look at two of our biggest-trending stories over the past few weeks: New technology tools and new pharmaceuticals for children in 2020.

The NIH starts observational study of COVID-19 and MIS-C in children

With the United States still in the throes of a pandemic, nearly 400 pediatric health care providers share their struggles in getting patients back to the office, advocating for a COVID-19 vaccine, and working their way toward optimism in the face of the biggest health care challenge of their lives.

A teenager shares how students can connect, even in the COVID era.

A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition reminded practitioners of the 3 guiding principles of psychopharmacology.

At the virtual 2020 American Academy of Pediatrics National Conference & Exhibition, Dr Saul R Hymes discusses how climate change directly impacts infectious disease in children.

Dr Anthony Fauci speaks on "COVID-19: Public Health and Scientific Challenges" at the virtual 2020 American Academy of Pediatrics (AAP) National Conference & Exhibition

Three scientists discuss the global race for a COVID-19 vaccine.